Hypercortisolism attributable to hypersecretion of ACTH by a pi tuitary adenoma is an uncommon and progressively lethal disease. Because of its rarity, it has been difficult to collect a large series of patients in order to identify the prognostic factors influencing the outcome after transsphenoidal surgery. We conducted a multicenter, retrospective analysis of the early and la te results of surgical treat ment of Cushing's disease.
ease (3) . Other therapeutic options, such as bilateral adre nalectomy (4, 5) , medical therapy with adrenostatic drugs (6) , radiotherapy (7) , and radiosurgery (8) , have been proposed either as alternatives to pituitary surgery or as adjunctive therapy in cases of incomplete remission of the disease after operation. In the last decade, several institutions have re ported the results of transsphenoidal surgery in patients with Cushing's disease. Although most authors describe a remis sion rate of 70-90%, the only other available retrospective multicenter survey reported considerably less favorable re sults in centers in the United States (9) . Moreover, an in creasing rate of late recurrence of the disease to as high as 20% at 5-6 yr has been reported, especially in those series with the longest follow-up (10) (11) (12) (13) . The rarity of Cushing's disease has precluded the collection of a large series of pa tients undergoing transsphenoidal operation in the same institution, thus making it difficult to assess the preoperative and postoperative factors influencing the immediate and late outcome of the disease. To address this problem, we carried out a retrospective, multicenter study in European countries in order to gather enough patients who had undergone sur gery for Cushing's disease, thus allowing us to perform a meaningful analysis of the possible prognostic factors linked to either failure or recurrence.
Materials and Methods

Study design
Endocrine and neurosurgical centers throughout Europe were asked to participate in a retrospective study on the surgical treatment of Cush ing's disease; a study protocol was elaborated, discussed, and amended by all participants, and a questionnaire was prepared accordingly (a copy is available on request).
All consecutive patients at each center were included in the study when the following criteria were met: 1) planned transsphenoidal sur gery for suspected Cushing's disease. Criteria for the diagnosis of Cush ing's disease were not explicitly given because of the great variability of the diagnostic tests used in the different countries during the period of the study. However, from a survey conducted among the participating centers, patients were diagnosed to have Cushing's disease on the basis of at least the clinical picture and the lack of steroid suppression during low-dose dexamethasone administration, Patients for whom an opera tion had been scheduled but not completed because of technical failure or patients who were later found to harbor an ectopic ACTH-secreting tumor were also included on an intention-to-treat basis; 2) operation performed between January 1,1975, and December 31, '1990. The former limit was chosen because microsurgical removal of pituitary tumors was not common before 1975; and 3) no prior pituitary surgery.
The questionnaire had five sections. The first contained the general demographic data of the patient and the presumed year of onset of the disease. The second section contained endocrinological data (baseline cortisol, ACTH, and urinary steroid levels; ACTH and steroid responses to TRH/GnRH and to corticotropin-releasing hormone (CRH) admin istration; and results of bilateral inferior petrosal sinus sampling) and neuroradiological characteristics [plain skull radiography, computed tomography (CT) scan, and magnetic resonance imaging (MRI)]. The third section concerned surgical characteristics (date of surgery, type of surgery, and diameter, location, invasiveness, and histological confir mation of a pituitary lesion), early endocrinological postoperative eval uation, and the need for and the duration of postoperative glucocorticoid substitution therapy. The fourth section referred to the last available follow-up information (date of last visit; baseline cortisol, ACTH, and urinary steroid levels; present status of the patient and in the case of death, date and cause). If the patient had a clinical and biochemical recurrence of Cushing's disease after successful operation, participants were asked to complete the fifth section of the questionnaire concerning the endocrinological and neuroradiological characteristics of the patient at relapse.
Hormonal data were described qualitatively as high, normal, or low according to the reference limits applied in each center. Similarly, re sponses to stimulation tests were described as normal, high, or no response, as the large time span of the study and the different methods used throughout Europe for the measurement of hormone levels pre vented the possibility of any meaningful quantitative analysis. How ever, to keep the results as hom ogeneous as possible, general criteria for determining normal and pathological responses were given, Thus, an increment of ACTH levels of at least 50% over baseline or an increase of cortisol concentrations of at least 160 nm ol/L after the administration of TRH/GnRIi or both were required to define a paradoxical response to this test. Participants were requested to specify the criteria they used for classifying the response to the CRH test (ovine or human). ACTH and cortisol increments lower than 50% over baseline after CRH adminis tration were regarded as indicating no response. There was more vari ability in the definition of the upper normal limit because this is visually derived from data in normal controls tested in each center. Therefore, the classification of the response given by each investigator was usually accepted. The results of bilateral inferior petrosal sinus sampling in cluded the study of both basal and CRH-stimulated ACTH secretion in most cases. Because at the time the study was planned no patient with the ectopic ACTH-syndrome was known to show a baseline ACTH ratio greater than 1.4 between the petrosal sinus levels and the peripheral venous concentrations, this value was regarded as indicative of pituitary-dependent hypercortisolism (14, 15) . The same value has been used to indicate the presence of a left or right gradient at the pituitary level (15) . A detailed explanation of all definitions given in the questionnaire was included. All of the questionnaires received were individually checked for inconsistencies before statistical analysis.
jStatistical analysis
The major goal of the study was to detect the main prognostic factors linked to either failure of treatment or recurrence of Cushing's disease after transsphenoidal surgery. For this reason, analysis of the data was divided in two parts. In the first, the response of patients was categorized as either treatment failure, i.e. patients who needed additional therapy for persisting clinical and biochemical hypercortisolism, or as treatment success, i,e. patients who did not need any additional treatment as they showed clinical remission of the disease and return of a normal sup pression of steroid levels during low-dose administration of dexameth asone. If recurrence of the disease occurred within 6 months after sur gery, patients were considered as treatment failure.
In the second part, w e focused on the recurrence of Cushing's disease. In this analysis w e included only patients who were classified as treat ment success after surgery (see above). They were then subdivided into patients who had a relapse and those who did not have evidence of relapsing Cushing's disease until the last follow-up visit.
Quantitative variables are expressed as mean ± s e m . Qualitative data were analyzed by the ^sta tistic without Yates' correction. Quantitative variables were analyzed by the Mann-Whitney test to avoid assumption about the gaussian distribution.
The occurrence of relapse is related to the length of follow-up; there fore, the cumulative probability of no relapse during the follow-up was estimated by means of survival analysis [product-limit method accord ing to Kaplan and Meier (16)1. The differences in the disease-free ex perience among the classes of the investigated variables were tested by Breslow generalized Wilcoxon test (17) .
To obtain reliable estimates, the disease-free curve was stopped at 120 months, which is when the number of patients remaining at risk was approximately less then 5% of the starting sample. As some information was not gathered at the time of original diagnosis or treatment, missing data were dealt with by carrying out complete case analyses in which patients were excluded from particular analyses if their files did not contain data on the required variables.
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R esults
Patient characteristics
The total number of questionnaires received was 716. After careful scrutiny of the data, 668 forms were retained for final analysis. The reasons for exclusion of the remaining 48 ques tionnaires were the following: patients actually had Nelson's disease (n = 10); patients had been operated on after the date for inclusion in the study (n = 12); and important data were missing (n = 26). A clear preponderance of female patients was observed (female/male ratio: 3,32). Mean age at surgery was 38.2 ± 0.55 yr (range 8-84 yr, median 38 yr). The esti mated interval between onset of the disease and diagnosis of Cushing's disease was 53.3 ± 1.82 months (range 5-355 months, median 40), and the mean interval between diag nosis and surgery was 10.2 ± 1.05 months (range 1-342 months, median 3.4 months). Surgery was performed before 1981 in 95 patients (14.2%), between 1981 and 1985 in 277 patients (41.5%), and after 1985 in 296 patients (44.3%).
Mortality and morbidity
Perioperative mortality was defined either as any death occurring within 1 month from surgery or as death resulting from a complication of operation. The perioperative mortal ity rate was 1 .9% (13 patients). Death occurred between 5 and 134 days after operation. Of the patients who died, 3 were operated on before 1981 (3.2%), 6 were operated on between 1981 and 1985 (2.2%), and 4 were operated on after 1985 (1.4%). Major complications of surgery were reported in 97 patients (14.5%) and were distributed unevenly among cured and not cured patients. The most frequent adverse events were cerebrospinal fluid rhinorrhea (4.6%), diabetes insipi dus for at least 6 months (3.0%), meningitis (2.8%), vascular injury or profuse bleeding (1.3%), and pulmonary embolism (0.6%). Twenty-two patients experienced 2 or more compli cations. The most frequent association was meningitis after postoperative cerebrospinal fluid rhinorrhea (7 patients).
Early postoperative results
After operation, 158 patients (23.7%) were considered as treatment failure and 510 (76.3%) were judged to be in re mission. The percentage of failure varied among the different centers from 0% to 47.6% (median 18.2%). When considering only centers with at least 20 evaluable patients, the failure rate ranged from 7.4%-47.6% (median 1.4,6%). No significant association was found between the general demographic characteristics of the patients and the occurrence of failure. There was a nonsignificant trend toward a declining per centage of surgical failures in more recent years (28.4%, 25.6%, and 20.3% for the periods 1975-1980, 1981-1985, and 1986-1990, respectively) . Previous therapy with drugs, ra diotherapy, and partial adrenalectomy, alone or in combi nation, reported in 176 patients (26.5%), did not correlate with the outcome.
Baseline ACTH, cortisol, and urinary steroid levels were not associated with the outcome of surgery. Preoperative dynamic testing of ACTH and cortisol secretion with CRH and TRH/GnRH was reported in 208 and 100 patients, re spectively. Patients with normal or excessive ACTH and cortisol response to CRH showed a failure rate (22.9%) that was significantly lower than in the group with no response (44.0%; P < 0.05). The presence of a paradoxical increase of cortisol levels after TRH/GnRH administration, reported in 27 patients (27%), had a near-significant negative prognostic value (percentage of failure in this group 37% vs. 20.5% in the group without such response; P < 0.10).
Bilateral sampling of inferior petrosal sinus was per formed in 98 patients. The overall failure rate in this group (23.5%) was similar to that of patients who did not undergo the procedure (23.7%). Seventeen patients did not show a positive central-peripheral gradient but they were subjected to surgery nonetheless; 6 of them did not achieve remission of the disease, In the 3 patients lacking histological confir mation of a pituitary adenoma, an ectopic ACTH-syndrome was strongly suspected. However, at the last follow-up (4,35, and 40 months after surgery), no source of ectopic ACTH secretion was detected. In the patients with a gradient, the percentage of failure was significantly higher in patients who did not have a left or right gradient (50%) than in those who did have a left or right gradient (13.3% and 17.9%, respec tively; P < 0.05).
Visualization of the adenoma by CT, reported in 281 (47.7%) of 589 patients, was strongly correlated with a good outcome (failure rate of 14.9% as compared to 28.4% and 29.7% of patients with normal or equivocal findings, respec tively; P < 0.001). Analysis of MRI, although performed in only 115 patients, confirmed a similar trend (failure rate of 12.9% in patients in whom the adenoma was identified vs. 26 .4% in patients with no evidence of the tumor; P < 0.10).
Selective adenomectomy, selective adenomectomy with wide margins, and hemihypophysectomy had similar failure rates of 20.0%, 23.8%, and '19.7%, respectively. Total hypophysectomy still carried a failure rate of 32.5%, Failure of sur gery was common (69.6%) when the surgeon did not identify any lesion at surgery.
Macroadenomas (reported in 20.7% of the patients), extrasellar extension of the tumor (14.5%), and tumor inva siveness (6.7%) as well as the location of the adenoma did not influence the outcome of surgery. Lack of histological doc umentation of an ACTH-secreting adenoma was more fre quent in patients not in remission (47.1% vs. 16.6%; P < 0.001).
Evidence for an underlying misdiagnosed ectopic ACTH syndrome in the group not in remission after surgery was sought by reviewing the cause of death of the patients. Five of 26 patients died of cancer (metastatic tumor of unknown origin, uterine carcinoma, ovarian cancer, breast cancer, and metastatic carcinoid) 2, 10, 27, 42, and 57 months after op eration, respectively. In 2 additional patients, a clinical sus picion of ectopic syndrome was reported. Thus, misdiagno sis of ectopic ACTH-syndrome seems to be a possible explanation for the therapeutic failure in a small subgroup of patients.
Recurrences
The analysis of the recurrences included the 510 patients who were considered in remission after operation. One hun dred three patients (20.2%) were either lost to follow-up (15.1%) or died (5.1%) while they were still disease-free, after a mean follow-up of 24 ± 0.1 months (median = 13 months).
Sixty-five patients (12.7%) had clinical and biochemical recurrence of the disease during follow-up. Recurrence oc curred after a mean time of 39.3 months (median 33 months) within a range of 6-104 months. The overall disease-free curve is shown in Fig. 1 . There was a constant decline in the percentage of patients without relapse, approaching 83% at 60 months.
Demographic variables did not correlate with the risk of recurrence. Only younger age at surgery, i.e. less than 38 yr (the median population age), conferred a higher risk of re lapse, but the difference was of borderline significance (P = 0.055). The results of preoperative hormonal studies did not correlate with the occurrence of relapse. Only the paradoxical cortisol response to TRIT/GnRIT showed a weak but non significant (P < 0.10) association with relapse of disease (36.8% of patients with such a response vs. 17.9% of those without the abnormal response). Patients with preoperative visualization of the pituitary tumor by MRI or CT showed earlier recurrence after surgery (P < 0.03 and P -0.053, respectively) ( Fig. 1, upper 
Fkj. 1. A nalysis of the recurrence of Cushing's disease in the patients who were in rem ission after transsphenoidal operation. In th e upper loft, the disease-free survival in the whole group is shown (num bers in brackets represent patients at risk at the end of each year). In the upper right, the disease-free survival according to the presence of a normal {n = 220) or abnormal (n -239) pituitary CT scan am ong the 459 who w ere exam ined before surgery is reported. P atients w ith an abnormal preoperative CT scan had a higher risk of recurrence, but
the difference was of borderline significance (P = 0.053). In th e lower lefty the disease-free survival according to the early postoperative morning cortisol level is shown for the 482 patients for w hom the result w as available. P atients w ith undetectable (n ~ 94) and low (n. = 250) cortisol levels had fewer recurrences during follow-up than did patients with low-normal (n = 97) and high-normal (n ~ 41) cortisol levels. The overall difference am ong the four groups was highly significant (P < 0.0001). In the lower right, th e disease-free survival according to the length of glucocorticoid substitution therapy is reported for all of th e 510 patients who had successful operations. P atients who did not need any substitution therapy (n = 82) and those who required glucocorticoid replacem ent for less than 1 yr (n -248) showed a higher risk of recurrence than did patients treated for more than 1 yr (n = 180), T he overall difference among the three groups was highly significant (P < 0.000X).
extrasellar growth of the adenoma, and histologic confirma tion were not significantly different between the two groups of patients. Early postoperative assessment of steroid secretion was highly predictive of long-term outcome. Recurrences in creased from 4.3% in patients with postoperative, undetect able circulating cortisol levels to 26.3% in patients with highnormal levels (P < 0.0001) ( Fig. 1, lower left) . The same pattern occurred for postoperative urinary steroid measurement (P < 0.0001), even though the number of patients investigated was lower (n = 266). Early postoperative CRH test was performed in only 82 patients. Persistence of a normal or exaggerated cortisol response predicted a higher likelihood of recurrence (17.5% and 42.9%, respectively, vs. 0% of pa tients with no cortisol response; P < 0.01). Need for and duration of glucocorticoid substitution therapy were strongly and inversely correlated with the occurrence of re lapse (P < 0,0001) ( Fig. 1, lower right) . When replacement therapy was needed for more than 1 yr, the probability of recurrence of the disease at 5 yr was low (3% vs. 24% for glucocorticoid therapy less than 1 year and 47% in patients not requiring any substitution therapy).
D iscussion
Our survey study allowed us to asses the results of trans sphenoidal pituitary surgery in 668 patients throughout Eu rope who were operated on for Cushing's disease from 1975 to 1990 . In common with all multicenter and retrospective studies, our survey has inherent bias. Because of the great variability of methods used in the different countries and throughout the study period, we could not perform any quantitative analysis of hormonal data. However, the large number of patients and the long follow-up allow some con clusions to be drawn about immediate and late outcome. Our study confirms that transsphenoidal microsurgery is a safe procedure in patients with Cushing's disease, with a perio perative mortality rate of 1.9%, comparable with that of other large series from single institutions (11, 18, 19) .
The definition of successful operation rested mainly on clinical grounds, i.e. remission of signs and symptoms of hypercortisolism and no additional requirement for therapy to control hypercortisolism for at least 6 months. The latter criterion was chosen to lessen the probability of postopera tive misclassification such as cyclical Cushing's disease (20) . By these criteria, 510 patients (76.3%) were in remission of disease after operation, a percentage of success similar to that reported in other surgical series from single institutions (11, 13, 18, 19, 21-34; Table 1 ), even though the great variability in the definition of cure makes direct comparison of these results difficult.
Burch (9) , in a multicenter survey carried out in the United States in 1983, found a great variability in the remission rates, which ranged from 10-100%. In our multicenter study, the results were more homogeneous among the participating centers (from 52.4%-100%) and showed a trend toward higher remission rates in recent years, probably reflecting the increasing experience with the diagnosis and therapy of Cushing's disease. Single series published by particip ants in this survey are not included. a N egative predictive factor of im m ed iate outcome: no adenom a found at operation. 6 N egative predictive factor for recurrence: short duration o f replacem ent therapy. e N egative predictive factor o f im m ed iate outcome: extrasellar adenoma. d N egative predictive factor for recurrence: h igh er postoperative steroid levels. * N egative predictive factor for recurrence: no adenom a found at operation. f N egative predictive factor of im m ed iate outcome: in vasive adenoma. tt N egative predictive factor for recurrence; younger age* Ten p atien ts were subjected to rep eated pituitary exploration within 10 days of surgery because of m easurable cortisol levels.
S even teen patients u n d erw en t rep eat pituitary surgery 7-46 days after first operation because of persistent hypercortisolism.
Early outcome of surgery was associated with few pre operative characteristics. Among hormonal variables, only the lack of response to CRH had a predictive negative value. A similar result was reported by Pieters and co-workers (12) who showed that preoperatively the mean increment of cor tisol levels after the administration of CRH was higher in the group of successfully operated patients. As the absence of cortisol and ACTH response to CRH does not suggest a pituitary origin of hypercortisolism (35) , the higher failure rate in such patients might reflect misdiagnosis of an ectopic ACTH-syndrome. On the other hand, 14 of the 25 patients with a negative response to CRH had a remission after pi tuitary surgery, suggesting that at least 50% of these patients had pituitary tumors not responsive to CRH.
As already suggested by Pieters and co-workers (12) , pa tients with the paradoxical cortisol responsiveness to TRH/ GnRH had a trend toward a higher percentage of surgical failure, but unfortunately the number of patients who un derwent the test (100 subjects) was probably too small to allow adequate statistical analysis.
Since the early 1980s, bilateral inferior petrosal sinus sam pling has been introduced in order to identify with certainty the origin of ACTH hypersecretion (36) and to improve the surgical results by selecting the side of hemihypophysectomy in those patients with a negative pituitary exploration (37) . The latter expectation, however, has not been corrob orated by the same author (36) and by other groups (14, 15) , probably because the diagnostic accuracy in localizing the intrapituitary side of the adenoma did not reach the desired 100%. Our results, although showing no significant differ ence in the success rate among patients who did and did not undergo the procedure, do not allow definitive conclusions to be drawn about the impact of inferior petrosal sinus sam pling on surgical results because of the limited number of patients available for analysis (98 of 668).
Preoperative visualization of the pituitary lesion by either CT scan or MRI was associated with a better outcome, prob ably because identification and removal of the pathological tissue at operation was easier. On the other hand, this ad vantage was counterbalanced by a higher rate of tumor re currence (see below). These findings suggest that additional refinements of neuroradiological tools, leading to a more precise intrapituitary localization of small tumors in Cush ing's disease, should bring an important amelioration of the early surgical results in thè future.
Operative variables did not influence the outcome of sur gery, with the exception of a negative pituitary exploration and a negative histopathology. In the past, total hypophysectomy has been advocated as the procedure of choice in patients with Cushing's disease (23) because it was pre sumed that the improvement of postoperative results would counterbalance the sacrifice of anterior pituitary function. Our survey clearly shows that compared with hemi-or total hypophysectomy, a more conservative surgical approach does not reduce the success rate. At variance with data in GH-and PRL-se ere ting tumors (38, 39) , other variables such as tumor size, invasiveness, and extrasellar extension did not significantly affect the results, probably because only a mi nority of ACTH-secreting tumors possessed such features.
Thus, it may be necessary to analyze many more cases in order to detect a significant difference for these variables.
Until recently, the recurrence of Cushing's disease after successful operation was regarded as a rare event. Indeed, many surgical series, especially the oldest ones, reported few late relapses ( Table 1) . On die contrary, in recent years it has become clear that recurrence of the disease is more frequent than was previously thought ( Table 1 ). In our study, 65 (12.7%) of 510 patients in remission after surgery relapsed during a mean follow-up period of 57 months. Interestingly, the occurrence of relapses did not show any time-related plateau but did show a progressive upward trend, as first suggested by Guilhaume and co-workers (11) . This fact stresses the need for continued and careful monitoring of patients.
To date, and because of the few cases studied in each single surgical series, no clear preoperative characteristic has emerged as a strong predictive factor for the occurrence of relapse. Only younger age at surgery was suggested as car rying a higher risk of recurrence of disease (32) . Our results showing a higher risk of relapse in younger patients lend support to this suggestion. However, Magiakou and co workers (40) recently reported a low recurrence rate (6.3%) in a group of children with Cushing's disease who were operated on at the NIH.
Paradoxical responsiveness to TRH/GnRIT had a weak but nonsignificant correlation with recurrence of disease* However, a larger sample of patients is needed before definitive conclusions about the predictive value of the test can be drawn. Visualization of the adenoma by neuroradiological studies was correlated with a higher risk of relapse. To explicate the divergence between the immediate and late results, it is likely that adenomas visible at pituitary imaging are usually large enough to be easily detected by the surgeon, which explains the better immediate postoperative results. On the other hand, the larger the tumor, the higher the probability that some adenomatous cells may remain and eventually cause regrowth of the tumor.
Early pos topera ti ve results were strongly associated with late outcome. Increasing rates of recurrence were associated in ascending order with the postoperative levels of serum and urinary steroids, as previously suggested by Pieters and co-workers (12) . Similarly, the persistence of a cortisol re sponse after CRH administration was correlated with a higher risk of relapse. The same finding was reported pre viously (12, 41, 42) . After operation, normal secretion of ACTIT and cortisol, either at baseline or in response to CRH, might suggest that residual adenomatous tissue is still present, as normal corticotrophs should remain completely suppressed by the preoperative chronic hypercortisolism (33) . On the basis of this assumption, Trainer et al. (33) rec ommended early reoperation or radiotherapy in patients with detectable steroid levels after surgery. However, be cause in our series only 33 of 135 patients with normal post operative circulating cortisol levels had a relapse, we em phasize that normal steroid levels after surgery are not necessarily followed by recurrence of the disease, making the aggressive policy of early reoperation and radiotherapy highly questionable, inasmuch as they often result in pan hypopituitarism and permanent diabetes insipidus (33) .
It is well known that after surgery most patients show transient secondary adrenal insufficiency requiring replace ment therapy with glucocorticoids for variable periods of time (43) . Our study clearly shows that the longer the need for glucocorticoid substitution, the higher the probability that the patient will remain free of disease in the long term ( Fig. 1, lower right) . When substitution therapy was needed for longer than 1 yr, the percentage of disease-free patients at 5 yr was 97%, whereas it declined to 76% and 53%, re spectively, when such therapy was required for less than 1 yr or not at all.
In conclusion, transsphenoidal surgery is a safe and ef fective treatment modality in patients with Cushing's dis ease, as confirmed in our multicenter study by the early success rate of about 76%. Moreover, our results show that recurrence of Oashing's disease is not a discrete phenomenon, inasmuch as it occurs progressively over the years with out any apparent tendency to plateau. Hypocortisolism after surgery is the most important factor predicting a good longterm outcome: the longer the need for glucocorticoid replacement, the lower the probability of relapse. However, although a careful follow-up is mandatory, early reoperation is not recommended in patients with normal steroid levels postoperatively in view of the high percentage of those who do not relapse.
